Reports for PENDOPHARM DIVISION OF PHARMASCIENCE INC

Company Name

PENDOPHARM DIVISION OF PHARMASCIENCE INC

Totals

Shortage reports

125

Actual shortage: 16 (13%)
Anticipated shortage: 0 (0%)
Avoided shortage: 5 (4%)
Resolved: 104 (83%)

Discontinuation Reports

3

To be discontinued: 0 (0%)
Discontinued: 2 (67%)
Reversed: 1 (33%)

Late reports

17 (13%)

Overdue reports

1 (6%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
XYLAC 50MG TABLET Actual shortage 2017-04-04 2018-12-22 5448
XYLAC 2.5MG TABLET Resolved 2017-06-12 2017-10-05 12630
XYLAC 2.5MG TABLET Resolved 2017-08-15 2017-10-05 19370
XYLAC 2.5MG TABLET Resolved 2024-02-22 2024-05-10 220293
XYLAC 2.5MG TABLET Resolved 2024-07-11 2024-09-23 232696

Showing 121 to 125 of 125

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
IBAVYR 400MG TABLET Discontinued 2023-01-20 2023-01-20 182029
IBAVYR 200MG TABLET Discontinued 2023-01-20 2023-01-20 182060
OCPHYL 500MCG SOLUTION Reversed 2017-04-10 2017-04-10 6237

Showing 1 to 3 of 3